온코닉테라퓨틱스

476060KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

13,770KRWMarket close of 10/21 (Wed)

Up +1.32%+180KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)13,070KRWDown -5.08%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
13,840
High
14,120
Low
13,670
Day range
Day range low 13,670 high 14,120, open 13,840, close 13,770, previous close 13,590
Volume
9×10K shares
1.2B KRW 0.45× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

1-year close range 9,510 to 26,300 won, 25% up from the low

25% of the way up from the lowest close in 1 year (251 sessions) · -47.6% from the high

Usual range

Nothing unusual in the 5 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Daily moveusual range+1.32%+1.32%, 0.5× the usual (20-session average ±2.49%)
    That day +1.32% · usual ±2.49% · large-move threshold ±5.0%
  • Trading valueusual range0.4×1.2B KRW, 0.4× the 20-session average
    0.45× the 20-session average · check threshold 3×

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+2.5B KRWusual range
  • Data date10/21 (Wed)Market close
See the full check report

Same sector · 바이오 R&D

Up +3.03%

· 33 of 64 stocks up, preferred shares excluded · trading value 215.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -5.5%Up +3.90%60.7B KRW
올릭스Close over the last 20 sessions -6.4%Up +9.53%26.1B KRW
디앤디파마텍Close over the last 20 sessions -6.0%Up +6.65%22.0B KRW
리가켐바이오Close over the last 20 sessions -14.3%Up +2.00%12.9B KRW
프로티나Close over the last 20 sessions +35.7%Up +7.23%11.0B KRW

Schedule

  • Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.